Milton H. Werner

Biography

"Prior to founding Inhibikase, Dr. Werner rebuilt research at the cell-free immunotherapeutics company Celtaxsys in Atlanta, Georgia. At Celtaxsys, Dr. Werner drove the research program from the loss of its technology license to a $20 million pre-money valuation at the opening of the Company’s Series B investment round. Celtaxsys explores the role of proteins in controlling immune cell migration. Previous to Celtaxsys, Dr. Werner was an internationally recognized scientist, Associate Professor and Head of Lab at the Rockefeller University. At the Rockefeller, Dr. Werner focused on elucidating mechanisms of human disease in immunology, oncology, and infectious disease. Dr. Werner received his Ph.D. in Chemistry from the University of California, Berkeley and trained at the National Institutes of Health before joining the Rockefeller in 1996. He is the author of more than 70 research articles, reviews, book chapters and has given lectures on his research work on more than 150 occasions throughout the world. He is recipient of numerous private and public research grants totaling more than $10 million. Dr. Werner is also the recipient of several awards, including the Young Investigator Award from the Sidney Kimmel Cancer Foundation, the Research Chair from the Brain Tumor Society and a $1 million prize from the W. M. Keck Foundation."

Research Interest

clinical science